The tissue factor pathway in ischemic stroke

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 7, 2006, Pages 527-532

  Adams, Murray J ^a   Thom, Jim ^b   Hankey, Graeme J ^b,c   Baker, Ross ^b   Gilmore, Grace ^b   Staton, Janelle ^b   Eikelboom, John W ^d,e  

^a CURTIN UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d MCMASTER UNIVERSITY   (Canada)

^e McMaster Clinic   (Canada)

Author keywords

Factor VII; Stroke; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

ANTIGEN; BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR 7; FREE TISSUE FACTOR PATHWAY INHIBITOR ANTIGEN; THROMBOPLASTIN; TISSUE FACTOR ANTIGEN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CEREBROVASCULAR ACCIDENT; COMPLEX FORMATION; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; RISK FACTOR; UPREGULATION;

AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; COHORT STUDIES; FEMALE; HUMANS; MALE; STROKE; THROMBOPLASTIN; TIME FACTORS;

EID: 33748950634     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000245294.41774.06     Document Type: Article

References (27)

1. McVey JH. Tissue Factor Pathway. Baillieres Best Pract Res Clin Haemat 1999; 12:361-372.
2. Butenas S, Van't Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 1997; 21:527-521.
3. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ. Cloning and characterisation of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem kunitz-type inhibitory domains. J Biol Chem 1988; 263:6001-6004.
4. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, et al. Functional significance of the kunitz type inhibitor domains of lipoprotein associated coagulation inhibitor. Nature 1989; 338:518-520.
5. Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2002; 22:539-548.
6. Lindahl AK, Sandset PM, Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 1992; 3:439-449.
7. Hubbard AR, Jennings CA. Inhibition of the tissue factor-factor VIIa complex: involvement of factor Xa and lipoproteins. Thromb Res 1987; 46:527-537.
8. Novotny WF, Girard TF, Miletich JP, Broze GJ. Purification and characterisation of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem 1989; 264:18832-18837.
9. Novotny WF, Girard TF, Miletich JP, Broze GJ. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 1988; 72:2020-2025.
10. Golino P, Ravera A, Ragni M, Cirillo P, Piro O, Chiariello M. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes. Circulation 2003; 108:2864-2869.
11. Abumiya T, Yamaguchi T, Terasaki T, Kokawa T, Kario K, Kato H. Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients. Thromb Haemost 1995; 74:1050-1054.
12. He M, Wen Z, He X, Xiong S, Liu F, Xu J, et al. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. Thromb Res 2002; 107:223-228.
13. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocysteine and ischemic stroke due to large and small artery disease but not other etiological subtypes of ischemic stroke. Stroke 2000; 31:1069-1075.
14. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Org 1976; 54:541-553.
15. Warlow CP, Dennis MS, Van Gijn J, Hankey GJ, Sandercock PAG, Bamford JM. Stroke: a practical guide to management, 2nd ed. Oxford: Blackwell Scientific Productions; 2000.
16. Sandset PM, Larsen ML, Abildaard U, Odegaard OR. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol. Blood Coagul Fibrinolysis 1991; 2:425-433.
17. Eilertsen KE, Osterud B. Tissue factor: (patho)physiology and cellular biology. Blood Coagul Fibrinolysis 2004; 15:521-538.
18. Lindmark E, Siegbahn A. Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin. Thromb Res 2002; 108:77-84.
19. Kopp CW, Steiner S, Priglinger U, Christ G, Probst P, Maurer G, et al. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting. Blood Coagul Fibrinolysis 2003; 14:379-386.
20. Sebestjen M, Keber I, Zegura B, Simcic S, Bozic M, Fressart MM, et al. Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors. Thromb Haemost 2004; 92:1129-1135.
21. Bartok A, Steiner S, Seidinger D, Jetzl A, Huber K, Minar E, et al. Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor. Thromb Res 2005; 115:469-474.
22. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2:533-537.
23. Kario K, Duell PB, Matsuo T, Sakata T, Kato H, Shimada K, et al. High plasma homocysteine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage. Atherosclerosis 2001; 157:441-449.
24. Kang WY, Wang HL, Xiong LF, Wang XF, Chu HY, Qu B, et al. Polymorphisms of the coagulation factor VII gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations. Chin Med J (Engl) 2004; 117:71-74.
25. Dahm AE, Andersen TO, Rosendaal F, Sandset PM. A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI). J Thromb Haemost 2005; 3:651-658.
26. Hansen JB, Huseby KR, Huseby NE, Ezban M, Nordoy A. Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro. Thromb Res 1997; 85:413-425.
27. Hirsh J, O'Donnell M, Weitz JI. New anticoagulants. Blood 2005; 105:453-463.